Orthometrix, Inc.
OMRX · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.01 | 1.02 |
| FCF Yield | -33.63% | -64.36% | -13.88% | 4.95% |
| EV / EBITDA | -16.39 | -16.57 | -23.76 | 76.04 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 9.68% | 30.13% | 46.99% | 46.07% |
| Cash Conversion Ratio | 0.54 | 1.15 | 0.79 | -0.63 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.33% | -0.94% | 6.97% | 16.74% |
| Free Cash Flow Growth | 45.18% | -59.05% | -311.93% | 474.28% |
| Safety | ||||
| Net Debt / EBITDA | -13.77 | -13.87 | -14.40 | 0.29 |
| Interest Coverage | 3.43 | 2.10 | 1.53 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.25 | 0.36 | 0.45 | 0.72 |
| Cash Conversion Cycle | -484.90 | -286.39 | -281.55 | -164.36 |